Unveiling the Dangers of EVALI: The Hidden Risks of Vaping

In this episode, we delve into the serious medical condition known as EVALI, which stands for e-cigarette or vaping product use-associated lung injury. Initially reported in 2012, EVALI saw a significant outbreak in the United States during the summer of 2019, leading to numerous hospitalizations and even fatalities.

We explore the primary symptoms, including shortness of breath, cough, and chest pain, and discuss how these were linked to the use of vaping products within the previous three months. The CDC recorded 2,807 cases and 68 deaths attributed to EVALI, though cases have significantly decreased since their peak in 2019.

Our discussion highlights the main risk factors, particularly focusing on the use of THC-containing vaping devices and products sourced from informal markets. We also examine the role of vitamin E acetate, a synthetic form of vitamin E found in THC vaping products, which has been identified as a key culprit in lung damage.

Additionally, we cover the challenges in diagnosing EVALI, as there are no specific diagnostic tests available. Instead, doctors rely on patient history and imaging tests like chest X-rays or CT scans. Finally, we touch on the CDC's recommendations for avoiding vaping products from black markets and the main treatment options available, including corticosteroids, supplemental oxygen, and mechanical ventilation.

Join us as we uncover the hidden risks of vaping and discuss the importance of using FDA-approved products to safeguard your health.